Clinical Trial Update: Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial named REFINE is evaluating the efficacy of rituximab for generalized myasthenia gravis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Myasthenia Gravis, Generalized | Phase 3 | Status: RECRUITING